Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 08.09.2025 1 Am J Hypertens 2 Am J Med 1 Biochem Biophys Res Commun 1 BMC Ophthalmol 1 BMC Pediatr 3 Circulation 1 Clin Chem 3 Diabet Med 3 Diabetes 3 Diabetes Care 23 Diabetes Obes Metab 6 Diabetologia 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 1 J Am Soc Nephrol 1 J Clin Endocrinol Metab 1 J Clin Invest 4 J Diabetes Complications 1 JAMA 1 Med J Aust 1 Metabolism 3 N Engl J Med 2 Nature 2 Pediatr Diabetes 1 Pediatrics 1 PLoS Genet 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hypertens

1. VASILEIADIS I, Zografou A, Platanias C, Papalysandrou A, et al
   Treatment targets for blood pressure lowering in patients with diabetes mellitus.
   Am J Hypertens. 2025 Sep 2:hpaf179. doi: 10.1093.
   PubMed        
   
   

   
   Am J Med

2. SANTANA R, Umana CD, Oo ZT, Kolli ST, et al
   Optimizing Guideline-Directed Medical Therapy in Chronic Kidney Disease and Type 2 Diabetes Mellitus Patients in Primary Care.
   Am J Med. 2025 Sep 1:S0002-9343(25)00562-5. doi: 10.1016/j.amjmed.2025.
   PubMed         Abstract available
   
   
3. YANG Y, Zhang X, Guo J, Zhai R, et al
   Transient Diabetes Insipidus Following Septic Shock due to Non-Intracranial Infection.
   Am J Med. 2025 Aug 30:S0002-9343(25)00571-6. doi: 10.1016/j.amjmed.2025.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

4. GUNAGAMBHIRE PV, Rudrappa M, Nayaka S
   Myco-nanofabrication of silver nanoparticles from Clonostachys byssicola PSEF1: Characterization, and exploration of its antimicrobial, antioxidant, anti-diabetic, anti-inflammatory and anticancer property on liver cancer cells.
   Biochem Biophys Res Commun. 2025;781:152544.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

5. THAPA R, Sharma S, Thakali S, Poudel M, et al
   Adherence to diabetic retinopathy care and barriers to service utilization in Nepal.
   BMC Ophthalmol. 2025;25:494.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

6. HASSAN M, ElHelaly M, Badawi N, Nader M, et al
   Impact of tailored diabetes education on adherence and glycemic control in children and adolescents on continuous subcutaneous insulin infusion, prospective interventional study in a tertiary center.
   BMC Pediatr. 2025;25:670.
   PubMed         Abstract available
   
   

   
   Circulation

7. SHI F, Zheng B, Liu Y
   Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
   Circulation. 2025;152:e71-e72.
   PubMed        
   
   
8. SILBERNAGEL G, Wen Y, Konrad RJ
   Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
   Circulation. 2025;152:e73-e74.
   PubMed        
   
   
9. HUANG J
   Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
   Circulation. 2025;152:e69-e70.
   PubMed        
   
   

   
   Clin Chem

10. FORD AM, Rubio Tapia A
    The Devil Is in the Details: Clinical Relevance of Serologic Antibody Titers to Predict the Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes.
    Clin Chem. 2025 Sep 3:hvaf102. doi: 10.1093.
    PubMed        
    
    

    
    Diabet Med

11. YU A, Whitfield K, Hale A, Ballard E, et al
    The positive impact of a multidisciplinary preoperative diabetes clinic on improving glycaemic management in adults undergoing elective noncardiac surgery.
    Diabet Med. 2025 Sep 3:e70131. doi: 10.1111/dme.70131.
    PubMed         Abstract available
    
    
12. SEIDU S, Tetteh J, Kunutsor S, Choudhary P, et al
    Prescription distribution and inequities in diabetes care: A comparative analysis of continuous glucose monitoring access by diabetes status, ethnicity and socio-economic factors in England.
    Diabet Med. 2025 Sep 3:e70130. doi: 10.1111/dme.70130.
    PubMed         Abstract available
    
    
13. DONIS R, Wakeling MN, Jeffery N, Govier M, et al
    Neonatal diabetes mellitus is a significant feature of COXPD-24 caused by recessive NARS2 variants.
    Diabet Med. 2025 Aug 31:e70129. doi: 10.1111/dme.70129.
    PubMed         Abstract available
    
    

    
    Diabetes

14. DE KLERK JA, Slieker RC, Parker WC, Wu H, et al
    Cell Type-Specific Expression of Long Noncoding RNAs in Human Diabetic Kidneys Identifies TARID as a Key Regulator of Podocyte Function.
    Diabetes. 2025 Sep 3:db250272. doi: 10.2337/db25-0272.
    PubMed         Abstract available
    
    
15. PANG P, Liu Y, Song H, Ye Z, et al
    Application of Dental Pulp Stem Cell-Derived Intracellular Vesicles for Diabetic Wound Healing.
    Diabetes. 2025 Sep 4:db240686. doi: 10.2337/db24-0686.
    PubMed         Abstract available
    
    
16. DING Y, Zhou Q, Jiang Y, Cao Q, et al
    Heterogeneity in Phenotype and Early Metabolic Response to Lifestyle Interventions in Type 2 Diabetes in China Using a Tree-Like Representation.
    Diabetes. 2025 Sep 4:db250197. doi: 10.2337/db25-0197.
    PubMed         Abstract available
    
    

    
    Diabetes Care

17. KAHKOSKA AR, Pate V, Pratley RE, Jonsson-Funk M, et al
    Use of a Claims-Based Algorithm to Characterize Uptake of Continuous Glucose Monitoring Among Older Adults With Type 1 and Type 2 Diabetes Meeting Medicare Coverage Criteria From 2017 to 2019.
    Diabetes Care. 2025 Sep 3:dc251593. doi: 10.2337/dc25-1593.
    PubMed        
    
    
18. BILAL A, Yi F, Whitaker K, Khan ZA, et al
    Effects of Continuous Glucose Monitoring on Impaired Awareness of Hypoglycemia in Older Adults With Type 1 Diabetes: A Post Hoc Analysis of the WISDM Study.
    Diabetes Care. 2025 Sep 3:dc250971. doi: 10.2337/dc25-0971.
    PubMed         Abstract available
    
    
19. GORDON HG, Shub A, Walker SP, Hiscock RJ, et al
    Maternal Diabetes, Fetal Growth and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia.
    Diabetes Care. 2025 Sep 3:dc250833. doi: 10.2337/dc25-0833.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. AKINRIMISI OI, Koning M, Scheijen JLJM, Meijnikman AS, et al
    Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals.
    Diabetes Obes Metab. 2025;27:5878-5888.
    PubMed         Abstract available
    
    
21. PENG Y, Li J, Deng Y, Zhou Z, et al
    The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression.
    Diabetes Obes Metab. 2025 Sep 5. doi: 10.1111/dom.70092.
    PubMed         Abstract available
    
    
22. CHAO Y, Tong X, Zhang B, Yang H, et al
    Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16-week randomised controlled trial.
    Diabetes Obes Metab. 2025 Sep 5. doi: 10.1111/dom.70103.
    PubMed         Abstract available
    
    
23. SOLA C, Lundemose SB, McCarthy OM, Norgaard K, et al
    Post-exercise glycaemic control for 24 h: Fasted morning exercise with and without glucagon in adults with type 1 diabetes using automated insulin delivery.
    Diabetes Obes Metab. 2025 Sep 4. doi: 10.1111/dom.70085.
    PubMed        
    
    
24. IPAYE T, Goldney J, Wilkinson TJ, Zaccardi F, et al
    Weight loss interventions and obesity-associated cancers in people with type 2 diabetes and overweight/obesity: A real-world observational study.
    Diabetes Obes Metab. 2025 Sep 3. doi: 10.1111/dom.70090.
    PubMed         Abstract available
    
    
25. THAMMAKOSOL K, Jantarapootirat M, Traiwanatham S, Sriphrapradang C, et al
    Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
    Diabetes Obes Metab. 2025 Sep 3. doi: 10.1111/dom.70101.
    PubMed         Abstract available
    
    
26. XIAO Q, Zhang C, Jiang Y, Suo C, et al
    Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles.
    Diabetes Obes Metab. 2025 Sep 3. doi: 10.1111/dom.70056.
    PubMed         Abstract available
    
    
27. CHO Y, Jhee JH, Jhee JH, Park HS, et al
    Beyond BMI: The role of diabetes and central obesity in fracture risk-Insights from the UK biobank.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70074.
    PubMed         Abstract available
    
    
28. ALHAMAR G, Fallucca S, Richardson SJ, Torabi F, et al
    Raised levels of Interleukin-8 and myeloperoxidase in patients with recent onset type 1 diabetes.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70048.
    PubMed         Abstract available
    
    
29. SSEMMONDO E, Newham M, Deshmukh H, Wilmot EG, et al
    Baseline clinical factors associated with diabetes distress in dialysis patients: Insights from the ABCD audit data.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70076.
    PubMed         Abstract available
    
    
30. YU B, Li J, Yu Y, Sun Y, et al
    Proteomics-enabled learning machine algorithms enhance the prediction of cardiovascular diseases in patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70064.
    PubMed         Abstract available
    
    
31. WANG B, Liu KSN, Mak IL, Choi EPH, et al
    Impact of onset age of type 2 diabetes mellitus on risk of renal complications compared to age-matched non-diabetic patients: Two cohort studies in the United Kingdom and Hong Kong.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70061.
    PubMed         Abstract available
    
    
32. WEI J, Wu H, Wang N, Zhu J, et al
    Integrative proteomic analysis provides novel therapeutic insights for etiological subtypes of diabetes.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70088.
    PubMed         Abstract available
    
    
33. 
    Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind tria
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70086.
    PubMed        
    
    
34. HOLMAN N, Young B, Gregg EW, Wareham N, et al
    Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009-2019.
    Diabetes Obes Metab. 2025 Sep 1. doi: 10.1111/dom.70025.
    PubMed         Abstract available
    
    
35. MANCHANDA Y, Jones B, Carrat G, Ramchunder Z, et al
    Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001.
    Diabetes Obes Metab. 2025;27:5938-5949.
    PubMed         Abstract available
    
    
36. LIN YL, Hung YJ, Chen JH, Sung JY, et al
    Protective effect of metformin against dementia in patients with obesity: Results from a global federated health network analysis.
    Diabetes Obes Metab. 2025;27:5899-5909.
    PubMed         Abstract available
    
    
37. FERNANDEZ C, Nacher M, Rivera K, Marin-Canas S, et al
    Loss of beta-cell identity in human islets treated with glibenclamide.
    Diabetes Obes Metab. 2025;27:5782-5792.
    PubMed         Abstract available
    
    
38. WANG Z, Jin Z, Xiong Z
    Research progress of epidermal growth factor receptor in metabolic dysfunction-associated steatotic liver disease and related diseases.
    Diabetes Obes Metab. 2025;27:5418-5431.
    PubMed         Abstract available
    
    
39. WEN Y, Lemen D, Lin Y, Chen YQ, et al
    Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.
    Diabetes Obes Metab. 2025;27:5985-5995.
    PubMed         Abstract available
    
    
40. ZHOU J, Husain M, Li Y, Liu W, et al
    Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.
    Diabetes Obes Metab. 2025;27:5706-5715.
    PubMed         Abstract available
    
    
41. CARLIER L, De Ponthaud C, Jacqueminet S, Phan F, et al
    Perioperative use and accuracy of continuous glucose monitoring: A systematic review.
    Diabetes Obes Metab. 2025;27:5393-5408.
    PubMed         Abstract available
    
    
42. SATTAR N, Garcia-Perez LE, Rodriguez A, Kapoor R, et al
    Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.
    Diabetes Obes Metab. 2025;27:5386-5392.
    PubMed         Abstract available
    
    

    
    Diabetologia

43. CIVIT-URGELL A, Pena E, Bejar MT, Moscatiello F, et al
    bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06533.
    PubMed         Abstract available
    
    
44. GU X, Wei Y
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06531.
    PubMed        
    
    
45. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter].
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06532.
    PubMed        
    
    
46. PETKOVIC M, Leal EC, Sorensen AE, Jorgensen PT, et al
    Improved wound healing by dual inhibition of miR-146a-5p and miR-29a-3p supports a network action of dysregulated miRNAs in diabetic skin.
    Diabetologia. 2025 Sep 3. doi: 10.1007/s00125-025-06522.
    PubMed         Abstract available
    
    
47. MUNGKALASUT P, Chanda M, Jugnam-Ang W, Cheepsunthorn P, et al
    Glucose 6-phosphate dehydrogenase deficiency and Southeast Asian-specific mutations lower HbA(1c) levels in a Thai population: implications for diabetes diagnosis.
    Diabetologia. 2025 Sep 1. doi: 10.1007/s00125-025-06523.
    PubMed         Abstract available
    
    
48. JIA X, Wang S, Lin H, Zhu Y, et al
    Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Diabetologia. 2025 Aug 30. doi: 10.1007/s00125-025-06528.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

49. WANG J, Hormel T, Park DW, Haq S, et al
    Quantifying Choriocapillaris Flow Deficits in Diabetic Retinopathy Using Projection-Resolved OCT Angiography.
    Invest Ophthalmol Vis Sci. 2025;66:13.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

50. PACKER M, Zile MR, Kramer CM, DiMaria JM, et al
    Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis.
    J Am Coll Cardiol. 2025;86:696-707.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

51. FERREIRA JP, Mendonca L, Marques P, Neves JS, et al
    Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes.
    J Am Soc Nephrol. 2025 Sep 2. doi: 10.1681/ASN.0000000877.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

52. 
    Correction to: "Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2025 Sep 3:dgaf494. doi: 10.1210.
    PubMed        
    
    

    
    J Clin Invest

53. MEAKIN PJ, Coull BM, Tuharska Z, McCaffery C, et al
    Expression of Concern for Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.
    J Clin Invest. 2025;135:e199125.
    PubMed        
    
    

    
    J Diabetes Complications

54. VAIDYA D, Yeboah-Kordieh Y, Howard M, Hugenschmidt CE, et al
    Sex specific associations of sex hormones with brain volumes and cerebral blood flow: A cross sectional observational study within the look AHEAD type 2 diabetes cohort.
    J Diabetes Complications. 2025;39:109161.
    PubMed         Abstract available
    
    
55. FANG Y, Jing L, Zhu Y, Wang H, et al
    Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109162.
    PubMed         Abstract available
    
    
56. WANG X, Yang S
    Letter to "Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study".
    J Diabetes Complications. 2025 Aug 21:109156.
    PubMed        
    
    
57. HJORTKJAER HO, Rossing P, Kofoed KF
    Burden and progression of arterial calcification in type 1 diabetes predicts future cardiovascular disease.
    J Diabetes Complications. 2025;39:109152.
    PubMed         Abstract available
    
    

    
    JAMA

58. SCHNEIDER L
    1 in 4 US Adults With Diabetes Used Injectable GLP-1 Drugs Last Year.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.13363.
    PubMed        
    
    

    
    Med J Aust

59. ADAMS LA, Kemp WW, Muller KR, Powell EE, et al
    Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.
    Med J Aust. 2025;223:268-276.
    PubMed         Abstract available
    
    

    
    Metabolism

60. STUBBENDORFF A, Janzi S, Jukkola J, Morency M, et al
    Mini-review of the EAT-Lancet planetary health diet and its role in cardiometabolic disease prevention.
    Metabolism. 2025;172:156373.
    PubMed         Abstract available
    
    

    
    N Engl J Med

61. JASTREBOFF AM, Ryan DH, Bays HE, Ebeling PR, et al
    Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial.
    N Engl J Med. 2025 Jun 23. doi: 10.1056/NEJMoa2504214.
    PubMed         Abstract available
    
    
62. CARLSSON PO, Hu X, Scholz H, Ingvast S, et al
    Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.
    N Engl J Med. 2025;393:887-894.
    PubMed         Abstract available
    
    
63. HEROLD KC, Pober JS
    Replacement of Beta Cells for Type 1 Diabetes.
    N Engl J Med. 2025;393:917-921.
    PubMed        
    
    

    
    Nature

64. 
    Diabetes drug shows anti-ageing effects on chromsomes.
    Nature. 2025 Sep 5. doi: 10.1038/d41586-025-02838.
    PubMed        
    
    
65. DOLGIN E
    Hope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection.
    Nature. 2025 Sep 5. doi: 10.1038/d41586-025-02802.
    PubMed        
    
    

    
    Pediatr Diabetes

66. ISMAIL MM, Al-Hassan OA, Mohamadsalih G, Abdullah MA, et al
    Mauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource-Limited Countries.
    Pediatr Diabetes. 2025;2025:7047312.
    PubMed         Abstract available
    
    
67. 
    Corrigendum to "ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 Diabetes in Children and Adolescents".
    Pediatr Diabetes. 2025;2025:9814065.
    PubMed         Abstract available
    
    

    
    Pediatrics

68. BERGMANN KR, Abuzzahab MJ, Perepelista V, Udeogu J, et al
    Improving Emergency Department Care for Children With Medium- and High-Risk Diabetic Ketoacidosis.
    Pediatrics. 2025 Sep 5:e2024068959. doi: 10.1542/peds.2024-068959.
    PubMed         Abstract available
    
    

    
    PLoS Genet

69. DABBS-BROWN A, Liu C, Hui Q, Wilson PWF, et al
    Identification of gene-sex hormone interactions associated with type 2 diabetes among men and women.
    PLoS Genet. 2025;21:e1011470.
    PubMed         Abstract available
    
    

    
    PLoS One

70. FARIS TAUFEQ FY, Nordin ML, Katas H
    Upscaling, toxicity and efficacy of multifaceted dressing embedded with dsirna-loaded gold nanoparticles for enhancing diabetic wound treatment.
    PLoS One. 2025;20:e0327375.
    PubMed         Abstract available
    
    
71. GOEZ-MORA JE, Arbelaez-Cordoba N, Balcazar-Morales N, Rivadeneira PS, et al
    Validation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control.
    PLoS One. 2025;20:e0330121.
    PubMed         Abstract available
    
    
72. MAJCHEREK D, Ciesielski A, Sobczak P
    AI-driven analysis of diabetes risk determinants in U.S. adults: Exploring disease prevalence and health factors.
    PLoS One. 2025;20:e0328655.
    PubMed         Abstract available
    
    
73. MAHMUD MI, Reza MS, Akash MOA, Elias F, et al
    DFU_DIALNet: Towards reliable and trustworthy diabetic foot ulcer detection with synergistic confluence of Grad-CAM and LIME.
    PLoS One. 2025;20:e0330669.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.